跳至主要内容
临床试验/JPRN-UMIN000016667
JPRN-UMIN000016667已完成未知

Prediction of the pharmacokinetics of asunaprevir in patients with hepatitis C virus by gadoxetic-acid-enhanced-magnetic resonance imaging - Pharmacokinetics of asunaprevir by MRI

Juntendo University Nerima Hospital Department of Gastroenterology0 个研究点目标入组 90 人开始时间: 2015年3月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Y-93H NS5A polymorphism (pretreatment resistance-associated variants) 2) Co-infection with hepatitis B or HIV 3) Previous exposure to inhibitors of NS5A or NS3A protease 4) Evidence of viable hepatocellular carcinoma 5) Alanine aminotransferase of more than five times the upper limit of the normal range 6) Child-Pugh score greater than 7 7) Patients taking the following drugs:rifampicin,rifabutin,phenytoin, carbamazepine,phenobarbital,systemic administration of dexamethasone, St Johns wort 8) Hypersensitivity to gadoxetic acid 9) Estimated glomerular filtration rate under 40 mL/min/1.73m2

研究者

发起方
Juntendo University Nerima Hospital Department of Gastroenterology

相似试验